📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomes. (2012)

First Author: Wason JM

Attributed to: Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/10543406.2010.528104

PubMed Identifier: 22651118

Publication URI: http://europepmc.org/abstract/MED/22651118

Type: Journal Article/Review

Volume: 22

Parent Publication: Journal of biopharmaceutical statistics

Issue: 4

ISSN: 1054-3406